Brain Tumor Reports
54

Volume 18 Number 4
April 2016


Home > Publications > Brain Tumor Reports > Volume 18, Year 2016 > Number 4, April*


CONTENTS



BRAIN TUMORS
GLIOBLASTOMA
GLIOMAS
HIGH-GRADE GLIOMAS
LOW-GRADE GLIOMAS
MALIGNANT LYMPHOMAS
MENINGIOMA
METASTATIC TUMORS





BRAIN TUMORS



Farah P, Blanda R, Kromer C, Ostrom QT, Kruchko C, Barnholtz-Sloan JS.
Conditional survival after diagnosis with malignant brain and central nervous system tumor in the United States, 1995-2012.
J Neurooncol. 2016 Apr 19. [Epub ahead of print]
Source | Abstract | Similar articles




Sharma R, D'Souza M, Jaimini A, Hazari PP, Saw S, Pandey S, Singh D, Solanki Y, Kumar N, Mishra AK, Mondal A.
A comparison study of (11)C-methionine and (18)F-fluorodeoxyglucose positron emission tomography-computed tomography scans in evaluation of patients with recurrent brain tumors.
Indian J Nucl Med. 2016 Apr-Jun;31(2):93-102. doi: 10.4103/0972-3919.178254.
Source | Abstract | Full text | Similar articles



GLIOBLASTOMA



Campos B, Olsen LR, Urup T, Poulsen HS.
A comprehensive profile of recurrent glioblastoma.
Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.85. [Epub ahead of print]
Source | Abstract | Similar articles




Du Four S, Maenhout SK, Benteyn D, De Keersmaecker B, Duerinck J, Thielemans K, Neyns B, Aerts JL.
Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion.
Cancer Immunol Immunother. 2016 Apr 20. [Epub ahead of print]
Source | Abstract | Similar articles




Eryılmaz MK, Mutlu H, Yalçin Müsri F, Salim DK, Tazegül G, Coşkun HŞ.
Severe periocular bleeding induced by bevacizumab in a patient with recurrent glioblastoma multiforme.
J Oncol Pharm Pract. 2016 Apr 22. pii: 1078155216643858. [Epub ahead of print]
Source ! Abstract | Similar articles




Jia A, Pannullo SC, Minkowitz S, Taube S, Chang J, Parashar B, Christos P, Wernicke AG.
Innovative Hypofractionated Stereotactic Regimen Achieves Excellent Local Control with No Radiation Necrosis: Promising Results in the Management of Patients with Small Recurrent Inoperable GBM.
Cureus. 2016 Mar 17;8(3):e536. doi: 10.7759/cureus.536.
Source | Abstract | Full text | Similar articles




Rivoirard R, Chargari C, Guy JB, Nuti C, Peoc'h M, Forest F, Falk AT, Garin C, Adjabi A, Hoarau D, Fotso MJ, Langrand Escure J, Moriceau G, Fournel P, Boutet C, Magné N.
Clinical Impact of Bevacizumab in Patients with Relapsed Glioblastoma: Focus on a Real-Life Monocentric SurVey (SV1 Study).
Chemotherapy. 2016;61(5):269-74. doi: 10.1159/000443719. Epub 2016 Apr 9.
Source | Abstract | Similar articles




Schäfer N, Gielen GH, Kebir S, Wieland A, Till A, Mack F, Schaub C, Tzaridis T, Reinartz R, Niessen M, Fimmers R, Simon M, Coch C, Fuhrmann C, Herrlinger U, Scheffler B, Glas M.
Phase I trial of dovitinib (TKI258) in recurrent glioblastoma.
J Cancer Res Clin Oncol. 2016 Apr 21. [Epub ahead of print]
Source | Abstract | Similar articles



GLIOMAS



van der Sanden B, Ratel D, Berger F, Wion D.
Glioma Recurrence following Surgery: Peritumoral or Perilesional?
Front Neurol. 2016 Mar 31;7:52. doi: 10.3389/fneur.2016.00052. eCollection 2016.
Source | Abstract | Full text | Similar articles



HIGH-GRADE GLIOMAS



Choi SH, Jung SC, Kim KW, Lee JY, Choi Y, Park SH, Kim HS.
Perfusion MRI as the predictive/prognostic and pharmacodynamic biomarkers in recurrent malignant glioma treated with bevacizumab: a systematic review and a time-to-event meta-analysis.
J Neurooncol. 2016 Apr 23. [Epub ahead of print]
Source | Abstract | Similar articles




Wetmore C, Daryani VM, Billups CA, Boyett JM, Leary S, Tanos R, Goldsmith KC, Stewart CF, Blaney SM, Gajjar A.
Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021.
Cancer Med. 2016 Apr 25. doi: 10.1002/cam4.713. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



LOW-GRADE GLIOMAS



Heng MA, Padovani L, Dory-Lautrec P, Gentet JC, Verschuur A, Pasquier E, Figarella-Branger D, Scavarda D, André N.
Can metronomic maintenance with weekly vinblastine prevent early relapse/progression after bevacizumab-irinotecan in children with low-grade glioma?
Cancer Med. 2016 Mar 31. doi: 10.1002/cam4.699. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



MALIGNANT LYMPHOMAS



Igala M.
Unusual relapse of primary central nervous system lymphoma.
Springerplus. 2016 Mar 9;5:301. doi: 10.1186/s40064-016-1926-x. eCollection 2016.
Source | Abstract | Full text | Similar articles



MENINGIOMA



Tsutsui T, Miyashita K, Sabit H, Fukui I, Hayashi Y, Mizokami A, Ikeda H, Nagatani H, Nakada M.
Acute Progression of Recurrent Meningioma during Luteinizing Hormone-Releasing Hormone Agonist Treatment for Prostate Cancer.
World Neurosurg. 2016 Mar 30. pii: S1878-8750(16)30002-X. doi: 10.1016/j.wneu.2016.03.076. [Epub ahead of print]
Source | Abstract | Similar articles



METASTATIC TUMORS



Ma W, Li N, An Y, Zhou C, Bo C, Zhang G.
Effect of Temozolomide and Radiotherapy on Brain Metastatic Tumor: A Systematic Review and Meta-analysis.
World Neurosurg. 2016 Apr 9. pii: S1878-8750(16)30084-5. doi: 10.1016/j.wneu.2016.04.011. [Epub ahead of print]
Source | Abstract | Similar articles